JP2025509736A5 - - Google Patents

Info

Publication number
JP2025509736A5
JP2025509736A5 JP2024555118A JP2024555118A JP2025509736A5 JP 2025509736 A5 JP2025509736 A5 JP 2025509736A5 JP 2024555118 A JP2024555118 A JP 2024555118A JP 2024555118 A JP2024555118 A JP 2024555118A JP 2025509736 A5 JP2025509736 A5 JP 2025509736A5
Authority
JP
Japan
Application number
JP2024555118A
Other languages
Japanese (ja)
Other versions
JPWO2023178179A5 (https=
JP2025509736A (ja
Filing date
Publication date
Priority claimed from US17/695,259 external-priority patent/US20230097887A1/en
Application filed filed Critical
Priority claimed from PCT/US2023/064436 external-priority patent/WO2023178179A2/en
Publication of JP2025509736A publication Critical patent/JP2025509736A/ja
Publication of JPWO2023178179A5 publication Critical patent/JPWO2023178179A5/ja
Publication of JP2025509736A5 publication Critical patent/JP2025509736A5/ja
Pending legal-status Critical Current

Links

JP2024555118A 2022-03-15 2023-03-15 循環タンパク質を分解するための二官能性分子 Pending JP2025509736A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17/695,259 US20230097887A1 (en) 2018-04-09 2022-03-15 Bi-functional Molecules to Degrade Circulating Proteins
US17/695,259 2022-03-15
PCT/US2023/064436 WO2023178179A2 (en) 2022-03-15 2023-03-15 Bi-functional molecules to degrade circulating proteins

Publications (3)

Publication Number Publication Date
JP2025509736A JP2025509736A (ja) 2025-04-11
JPWO2023178179A5 JPWO2023178179A5 (https=) 2026-03-24
JP2025509736A5 true JP2025509736A5 (https=) 2026-03-24

Family

ID=88024435

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024555118A Pending JP2025509736A (ja) 2022-03-15 2023-03-15 循環タンパク質を分解するための二官能性分子

Country Status (8)

Country Link
EP (1) EP4493220A2 (https=)
JP (1) JP2025509736A (https=)
KR (1) KR20250004953A (https=)
CN (1) CN119212726A (https=)
AU (1) AU2023234543A1 (https=)
IL (1) IL315581A (https=)
MX (1) MX2024011358A (https=)
WO (1) WO2023178179A2 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2997444A1 (en) * 2015-09-29 2017-04-06 Amgen Inc. Asgr inhibitors for reducing cholesterol levels
US12364766B2 (en) * 2018-04-09 2025-07-22 Yale University Bifunctional small molecules to target the selective degradation of circulating proteins
WO2019199621A1 (en) * 2018-04-09 2019-10-17 Yale University Bi-functional molecules to degrade circulating proteins
CN113301925A (zh) * 2018-12-19 2021-08-24 小利兰·斯坦福大学理事会 用于溶酶体靶向的双官能分子以及相关的组合物和方法
IL294515A (en) * 2020-01-31 2022-09-01 Avilar Therapeutics Inc Compounds bind asgpr to degrade extracellular proteins

Similar Documents

Publication Publication Date Title
JP2022087358A5 (https=)
JP2025509736A5 (https=)
CL2025003668A1 (es) Composiciones farmaceuticas.
CN307045515S (https=)
CN307046102S (https=)
CN307049712S (https=)
CN307049662S (https=)
CN307049492S (https=)
CN307048415S (https=)
CN307048257S (https=)
CN307047768S (https=)
CN307047005S (https=)
CN307046266S (https=)
CN307046205S (https=)
CN307045950S (https=)
CN307044339S (https=)
CN307044188S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13140U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)